We are live on ! Find out more
LSA

L & S Advisors Portfolio holdings

AUM $967M
1-Year Est. Return 68.8%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+68.8%
3 Year Est. Return
+231.28%
5 Year Est. Return
+398.69%
10 Year Est. Return
+2,093.99%
AUM
$187M
AUM Growth
-$88.1M
Cap. Flow
-$98.8M
Cap. Flow %
-52.7%
Top 10 Hldgs %
52.28%
Holding
113
New
32
Increased
3
Reduced
45
Closed
33

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$4.66M
2
PFE icon
Pfizer
PFE
+$4.52M
3
BDX icon
Becton Dickinson
BDX
+$4.06M
4
EOG icon
EOG Resources
EOG
+$3.73M
5
UNP icon
Union Pacific
UNP
+$2.19M

Sector Composition

Rank Sector Weight
1 Communication Services 29.22%
2 Healthcare 18.39%
3 Industrials 17.53%
4 Energy 10.61%
5 Technology 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
26
Broadcom
AVGO
$1.67T
$2.08M 1.11%
+323,230
New +$1.89M
EMN icon
27
Eastman Chemical
EMN
$7.62B
$2.08M 1.11%
+24,097
New +$1.98M
DAL icon
28
Delta Air Lines
DAL
$52.2B
$2.07M 1.11%
59,869
-72,234
-55% -$2.32M
SLB icon
29
SLB Ltd
SLB
$77.5B
$2.07M 1.1%
+21,194
New +$1.92M
MCK icon
30
McKesson
MCK
$103B
$2.06M 1.1%
11,693
-22,805
-66% -$3.99M
RTN
31
DELISTED
Raytheon Company
RTN
$2.06M 1.1%
+20,889
New +$1.98M
AGN
32
DELISTED
Allergan plc
AGN
$2.06M 1.1%
10,023
-23,887
-70% -$4.73M
PPG icon
33
PPG Industries
PPG
$23.5B
$2.06M 1.1%
21,310
-19,134
-47% -$1.82M
TMO icon
34
Thermo Fisher Scientific
TMO
$242B
$2.06M 1.1%
+17,095
New +$2.03M
ROC
35
DELISTED
ROCKWOOD HLDGS INC
ROC
$2.06M 1.1%
+27,633
New +$2.04M
CMI icon
36
Cummins
CMI
$72.3B
$2.05M 1.09%
13,751
-14,731
-52% -$2.05M
TRN icon
37
Trinity Industries
TRN
$2.27B
$2.04M 1.09%
+78,501
New +$1.81M
FDX icon
38
FedEx
FDX
$72.4B
$2.03M 1.08%
15,338
-24,585
-62% -$3.34M
BAC icon
39
Bank of America
BAC
$408B
$2.03M 1.08%
117,961
-122,085
-51% -$2.05M
XLNX
40
DELISTED
Xilinx Inc
XLNX
$2.03M 1.08%
+37,381
New +$1.86M
PRGO icon
41
Perrigo
PRGO
$1.87B
$2.01M 1.07%
+13,023
New +$2.06M
GILD icon
42
Gilead Sciences
GILD
$185B
$2.01M 1.07%
28,410
-46,074
-62% -$3.61M
XLV icon
43
State Street Health Care Select Sector SPDR ETF
XLV
$43.7B
$1.25M 0.67%
21,434
-1,628
-7% -$93.8K
SMH icon
44
VanEck Semiconductor ETF
SMH
$69.4B
$972K 0.52%
+42,614
New +$916K
XBI icon
45
State Street SPDR S&P Biotech ETF
XBI
$10.6B
$936K 0.5%
19,716
-1,656
-8% -$84.8K
IHE icon
46
iShares US Pharmaceuticals ETF
IHE
$1.63B
$851K 0.45%
20,157
-1,716
-8% -$71.9K
XLK icon
47
State Street Technology Select Sector SPDR ETF
XLK
$122B
$837K 0.45%
46,064
-28,020
-38% -$500K
XLI icon
48
State Street Industrial Select Sector SPDR ETF
XLI
$30.7B
$832K 0.44%
15,898
-1,507
-9% -$77.4K
TRGP icon
49
Targa Resources
TRGP
$61.3B
$645K 0.34%
6,503
-348
-5% -$32.5K
SRE icon
50
Sempra
SRE
$53.6B
$557K 0.3%
+11,516
New +$535K

Similar funds

L & S Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, L & S Advisors held 113 positions worth $187M, down 32% from $276M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

L & S Advisors withdrew a net $98.8M in Q1 2014, closing 33 positions and reducing 45 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $5.48M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 29% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, L & S Advisors opened a new position in Merck worth $4.88M.

  • L & S Advisors's largest Q1 2014 buy was Merck: 90,043 shares worth $4.88M.
  • L & S Advisors added most to DuPont de Nemours in Q1 2014, an estimated $1.5M increase.
  • L & S Advisors's biggest Q1 2014 reduction was Meta Platforms (Facebook), cutting an estimated $10.8M.
  • L & S Advisors fully exited Canadian Pacific Kansas City in Q1 2014, selling an estimated $5.48M.
  • L & S Advisors's ten largest holdings make up 52% of its $187M portfolio in Q1 2014.
  • L & S Advisors opened 32 new positions and closed 33 in Q1 2014.
  • L & S Advisors's portfolio value fell 32% quarter-over-quarter to $187M.

Based on L & S Advisors's 13F filing for Q1 2014, filed 15 May 2014.